Business Description
Invizyne Technologies Inc
NAICS : 541715
SIC : 2834
Description
Invizyne Technologies Inc is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought-after chemicals. It believes that its biomanufacturing platform, known as SimplePath, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. its objective with SimplePath is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform consists of a series of modular cascading enzyme-based biomanufacturing systems that leverage natural processes to perform complex chemical conversions.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.05 | |||||
| Equity-to-Asset | -1.01 | |||||
| Debt-to-Equity | -1.35 | |||||
| Debt-to-EBITDA | -1.04 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 84.56 | |||||
| 9-Day RSI | 79.37 | |||||
| 14-Day RSI | 76.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.25 | |||||
| Quick Ratio | 0.25 | |||||
| Cash Ratio | 0.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -137.72 | |||||
| ROIC % | -106.59 | |||||
| ROC (Joel Greenblatt) % | -219.54 | |||||
| ROCE % | -19273.44 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -36.8 | |||||
| EV-to-EBITDA | -38.84 | |||||
| EV-to-FCF | -46.82 | |||||
| Earnings Yield (Greenblatt) % | -2.72 | |||||
| FCF Yield % | -2.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IZTC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Invizyne Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.63 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 76.17 | ||
| 14-Day ATR ($) | 2.275371 | ||
| 20-Day SMA ($) | 14.8825 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 8.5 - 20 | ||
| Shares Outstanding (Mil) | 9.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Invizyne Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Invizyne Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Invizyne Technologies Inc Frequently Asked Questions
What is Invizyne Technologies Inc(IZTC)'s stock price today?
The current price of IZTC is $19.30. The 52 week high of IZTC is $20.00 and 52 week low is $8.50.
When is next earnings date of Invizyne Technologies Inc(IZTC)?
The next earnings date of Invizyne Technologies Inc(IZTC) is .
Does Invizyne Technologies Inc(IZTC) pay dividends? If so, how much?
Invizyne Technologies Inc(IZTC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers